Vertice raises $50 million Series C to simplify procurement

By on    Internet, Picture Gallery, Software  

Vertice raises $50 million Series C to simplify procurement

Lakestar leads round with participation from existing investors Bessemer Venture Partners and 83North

Vertice, the spend optimization platform, today announced $50 million in Series C funding led by Lakestar. This investment brings the total raised to over $100 million. Additional participants include Perpetual Growth and CF Private Equity, alongside existing investors Bessemer Venture Partners and 83North.

This oversubscribed round is the latest milestone in Vertice s 2.5 year growth journey,

Infosys leads the industry with the fastest growing CAGR in brand value of 18% over 5 years. Maintains leadership as a global Top 3 IT services brand

By on    Internet, Software  

Infosys CEO Salil Parekh is the No.1 IT services CEO, for the second year in a row, in the Brand Guardianship Index 2025

Infosys (https://www.infosys.com/) (NSE: INFY) (BSE: INFY) (NYSE: INFY), a global leader in next-generation digital services and consulting, today announced that Brand Finance (https://brandfinance.com/), the world s leading brand valuation firm, has recognized the company as a Top 3 IT services brand and the fastest growing IT services brand globally, with a CAGR of 18% over

University of Melbourne and SMART Technologies partner in groundbreaking global research on technology supports for neurodivergent learners

By on    Internet, Picture Gallery  

University of Melbourne and SMART Technologies partner in groundbreaking global research on technology supports for neurodivergent learners

SMART Technologies and the University of Melbourne s collaborative research promise impactful ways to engage neurodivergent students.

SMART Technologies, a global leader in interactive education technology, has partnered with the University of Melbourne to launch the first-of-its-kind research initiative exploring how classroom environments can better support neurodivergent learners. The study identified key strategies and tools that promote engagement, reduce barriers, and empower these studen

Nomination period for the Broermann Medical Innovation Award started

By on    Electronics & Semiconductors, Picture Gallery  

Nomination period for the Broermann Medical Innovation Award started

– Prize money of one million euros higher than the prize money for the Nobel Prize for Medicine
– Award honors researchers worldwide who have done pioneering work in medicine, biotechnology, or related fields

The nomination period for the Broermann Medical Innovation Award has started. The prize, which will be awarded for the first time this year, is aimed at scientists worldwide who have carried out pioneering work in medicine, biotechnology, or related fields with their research.

The n

Infosys: Strong growth of 6.1% YoY in CC, 80 bps YoY operating margin expansion

By on    Internet, Software  

– Large deal TCV of $2.5 billion including 63% net new; Headcount increased by 5,591
– FY25 revenue guidance revised to 4.5%-5.0%

Infosys (NSE: INFY) (BSE: INFY) (NYSE: INFY), a global leader in next-generation digital services and consulting, delivered strong and broad-based performance with $4,939 million in Q3 revenues, growth of 1.7% sequentially and 6.1% year on year in constant currency. Operating margin for Q3 was at 21.3%, increase of 0.2% sequentially. Free cash flow for Q3 was high

Infosys and Tennis Australia Create New Generative AI Innovations at the Australian Open 2025

By on    Internet, Software  

Launch of Beyond Tennis : A new generative AI tennis league with AI players and data-driven tournaments

Infosys (https://www.infosys.com/) (NSE: INFY), (BSE: INFY), (NYSE: INFY), a global leader in next-generation digital services and consulting, in partnership with Tennis Australia (https://apc01.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.tennis.com.au%2F&data=05%7C02%7CShruti.Pai%40infosys.com%7Ce74a953ce42e4341f62a08dd33a3fc68%7C63ce7d592f3e42cda8ccbe764cff5eb6%7C0%7C0%7C63

BAIBYS™ Announces a Breakthrough in Fertility Treatment with a Newly CE Marked IVF System

By on    Internet  

The Autonomous Sperm Selection AI-based Robotic System is Poised to Transform the IVF Market

BAIBYS™ (https://www.baibys.com/), a pioneering Israeli startup in AI-powered micro-robotics for Artificial Reproductive Technology (ART), today announced it has received the CE mark for its innovative BAIBYS™ system (https://www.youtube.com/watch?v=Vaa_HlxuAm0). This milestone enables the company to commercialize its autonomous sperm selection technology across Europe, marking a significant

Spectral Achieves Major Patent Milestone Related to Quantum Computing

By on    Computer & Software, Picture Gallery  

Spectral Achieves Major Patent Milestone Related to Quantum Computing

SEATTLE, WA, Jan 6, 2025 – (ACN Newswire) – Spectral Capital Corporation (OTCQB: FCCN), a pioneer in Quantum as a Service (QaaS) computing and decentralized cloud infrastructure, is pleased to announce the achievement of a major patent milestone as the first step in its plan to become a globally competitive leader in quantum computing patents.

"According to the World Intellectual Property Organization ("WIPO"), there were 350,000 patents filed worldwide in classical computing. An

Norgine submits Marketing Authorisation Application to the European Medicines Agency for eflornithine (difluoromethylornithine [DFMO]) in high-risk neuroblastoma

By on    Internet, Picture Gallery  

Norgine submits Marketing Authorisation Application to the European Medicines Agency for eflornithine (difluoromethylornithine [DFMO]) in high-risk neuroblastoma

Back to media releases (https://norgine.com/media)

Next media release (https://norgine.com/press_release/norgine-receives-positive-chmp-opinion-recommending-approval-of-npj5008-dantrolene-sodium-hemiheptahydrate-for-the-treatment-of-malignant-hyperthermia/)

Norgine today announced that it completed its marketing authorisation application filing to European Medicines Agency (EMA) for eflornithine in high-risk neuroblastoma (HRNB). This follows the submissions in April 2024, via Project Orbis, i

1 2 3 4 5 6 … 7,764